Biotech

All Articles

Otsuka spends $800M for Jnana and also its clinical-stage PKU medicine

.Otsuka Pharmaceutical has actually picked up Boston-based Jnana Therapeutics for $800 million so th...

FibroGen lays off 75% people workers as asset fails 2 more tests

.FibroGen is radically restructuring its own service, laying off 75% of its united state team and al...

Tracon wane weeks after injectable PD-L1 inhibitor stop working

.Tracon Pharmaceuticals has made a decision to wind down procedures full weeks after an injectable i...

Ideaya bags choice on Biocytogen bispecific ADC in $400M bargain

.Ideaya Biosciences is wagering $400 thousand in biobucks that a bispecific antibody-drug conjugate ...

Takeda takes $140M loss on stopped working epilepsy medicine, boasts FDA run

.We actually know that Takeda is actually intending to discover a path to the FDA for epilepsy medic...

VBI Vaccinations files for insolvency, finds possession sale

.Immunology biotech VBI Vaccines is actually diverting hazardously near to the defining moment, with...

Celldex anti-cKIT antibody decrease hives in another stage 2 research study

.It is actually difficult to muscle mass in on a room as competitive as immunology, however Celldex ...

Boehringer offers up to $1.3 B for gate prevention biotech

.Boehringer Ingelheim is actually offering up to $1.3 billion for Nerio Therapies and a preclinical ...

Ventyx's last resort for inflamed med ends in Crohn's breakdown

.Ventyx Biosciences' Crohn's condition medicine performed not help individuals achieve remission in ...

Cognition's phase 2 SHINE information tarnish Alzheimer's prospect

.Knowledge Therapeutics' period 2 luster trial has taken several of the luster off the Alzheimer's a...